Orthocell - Model Ortho-ACI - Autologous Chondrocyte Implantation Brochure

Millions of people worldwide suffer pain and limited mobility as a result of damage to articular cartilage, most commonly in the knee or ankle. Unfortunately, unlike muscle or bone, damaged cartilage has a limited capacity for self-repair. Left untreated, the cartilage damage progresses to the point where joint replacement is required. Orthocell`s Autologous Chondrocyte Implantation (Ortho-ACI™) offers treatment for symptomatic defects of the articulating cartilage of the joints. Ortho-ACI™ uses the patient’s own healthy cartilage cells, called chondrocytes, to assist the regeneration of damaged cartilage. ACI was first introduced in 1987, and thousands of implants have been performed world-wide. ACI is a highly customisable, personalised treatment - each procedure is tailored to the individual patient’s requirements. Over 500+ patients treated using Ortho-ACI™ in Australia, Singapore and Hong Kong.